Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dispute Resolution Panel Plans Solidify As CDRH Weighs Industry Comments

This article was originally published in The Gray Sheet

Executive Summary

FDA intends to publish a Federal Register notice within the next three weeks seeking applicants to fill three standing voting positions on its Medical Devices Dispute Resolution Panel, as well as one industry and one consumer representative, according to FDA staffers.

You may also be interested in...



Dispute Resolution Guidance Flouts FDAMA And Favors CDRH, HIMA Says

The draft guidance on scientific dispute resolution recently issued by the Center for Devices and Radiological Health places too much "gatekeeping" authority in the hands of device center officials, the Health Industry Manufacturers Association maintains in comments submitted to FDA July 19.

CDRH Dispute Resolution Guidance Spells Out Panel Membership, Timeframes

The dispute resolution panel proposed by FDA's Center for Devices and Radiological Health will consist of eight members, one of whom will be a non-voting industry representative, the agency says in a draft guidance document released April 27.

Indoco Counts On Indian Market Bouncing Back

Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump.  The Indian company continues to perform well internationally and grow overall.

UsernamePublicRestriction

Register

LL010986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel